Product Images Divalproex Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Divalproex Sodium NDC 70518-2510 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

MM1 - Divalproex Sodium 500mg 70518 2510 00

MM1 - Divalproex Sodium 500mg 70518 2510 00

Divalproex Sodium Extended-Release 500 mg Tablets in a quantity of 100 are available for prescription-only purchase. The manufacturer is Amneal Pharma based in Ahmedabad, India. The packaging includes a LOT number and an expiration date. Directions for use are stated in the package insert, and the tablets should be kept out of the reach of children. The product must be stored at a temperature ranging from 20-26°C. It has been repackaged by RemedyRepack Inc., Indiana.*

MM2 - Divalproex Sodium 500mg 70518 2510 01

MM2 - Divalproex Sodium 500mg 70518 2510 01

This is a prescription medicine named Divalproex Sodium Extended-Release 500mg Tablet, repackaged by RemedyRepack Inc. It is manufactured by Amneal Pharma in Ahmedabad, India. It comes in a pack size of 1 HD2 and its NDC number is 70518-25610-01. It is advised to keep out of reach of children and to store at a temperature of 20-26°C (63-77°F), with excursions permitted to 15-30°C (59-86°F). Directions for use are mentioned in the package insert. The expiration date and lot number are not available.*

MM3 - Divalproex Sodium 500mg 70518 2510 02

MM3 - Divalproex Sodium 500mg 70518 2510 02

This is a description of a medication called Divalproex Sodium Extended-Release. Each tablet has a strength of 500 mg and is sold in a package of 30 tablets. The medication is only available with a prescription. The package has an NDC number: 70518-2510-02; a LOT number and an expiration date must be added. The tablets were manufactured by Amneal Pharma located in Ahmedabad, India, and were repackaged by Remedy Repack Inc. in Indiana. The medication should be stored at temperatures between 20-26°C (63-77°F) with small excursions from 15-30°C (59-86°F) being permitted. Users should follow the directions provided in the package insert and keep this medication out of the reach of children.*

MM4 - Divalproex Sodium 500mg 70518 2510 03

MM4 - Divalproex Sodium 500mg 70518 2510 03

This is a description of a medication called Divalproex Sodium. The medication is in an extended-release tablet form and each tablet contains 500mg. This package contains 30 tablets. The medication is for prescription use only and cannot be used without medical supervision. The package includes directions for use to be found in the package insert. The manufacturer of the medication is Amneal Pharma, located in Ahmedabad, India. The medication needs to be stored at a temperature between 20-26°C (63-77°F); excursions are permitted between 15-30°C (59-86°F). This package of Divalproex Sodium was repackaged by RemedyRepack Inc. in Indiana.*

MM5 - Divalproex Sodium 500mg 70518 2510 04

MM5 - Divalproex Sodium 500mg 70518 2510 04

Divalproex Sodium is an extended-release tablet with a strength of 500mg. This medication is only available through prescription and must be kept out of the reach of children. The manufacturer is Amneal Pharma based in Ahmedabad, India. The package insert should be followed for directions of use. The medication should be stored at a temperature range of 20-26°C (63-77°F) with excursions permitted to 15-30°C (59-86°F). The lot number and expiry date are not available. This medication was repackaged by RemedyRepack Inc. located in Indiana, PA.*

10 - divalproex sodium extended release tablets usp 1

10 - divalproex sodium extended release tablets usp 1

Figure 1 - divalproex sodium extended release tablets usp 2

Figure 1 - divalproex sodium extended release tablets usp 2

Figure 2 - divalproex sodium extended release tablets usp 3

Figure 2 - divalproex sodium extended release tablets usp 3

The text seems to be a chart showing the reduction in CPS rate achieved by using high and low doses of Divalproex Sodium in patients. The chart displays percentages ranging from 0% to 100% on both axes, indicating the proportion of patients who showed improvement, no change, or worsening symptoms. The label at the top suggests that the chart is measuring the reduction in CPS rate (seizure frequency). There is not enough context to determine the units or the source of the data.*

Figure 3 - divalproex sodium extended release tablets usp 4

Figure 3 - divalproex sodium extended release tablets usp 4

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.